35th Symposium on Biotechnology for Fuels and Chemicals April 29 – May 2, 2013 Portland, OR, USA
April 22 – 25, 2013 Chicago, USA
ProteoNic has relocated its headquarters, expanding its facilities at the Leiden Bio Science Park, the Netherlands.
Leiden, Netherlands/Oxford, United Kingdom, March 7, 2013 – Dutch biotech company ProteoNic BV and Oxford Expression Technologies Ltd (OET), a leading provider of baculovirus-based protein expression products and services, have extended their partnership by signing a commercial license agreement. OET obtains the right to use ProteoNic’s UNic™ translation enhancing elements in its flashBAC™ system for third party recombinant protein production services. ProteoNic will provide technical support. Financial terms include upfront and royalty payments.
November 12 – 14, 2012 Hamburg (Germany)
November 5 – 6, 2012 London, UK
October 16 – 18, 2012 Dusseldorf (Germany)
Leiden, The Netherlands, September 28, 2011 – Dutch biotech company ProteoNic B.V. announces successful completion of a € 6 mln equity financing round led by US-based Fairbanks Investment Fund (FIF), with existing shareholders participating. The funding will be used to accelerate commercialization of ProteoNic’s proprietary UNic™ recombinant protein yield enhancement technology and expand the company’s capabilities in the area of cell line generation and contract services.